PanCancer IO 360™ Panel
Facilitating rapid discovery and development of potentially predictive signatures with the most advanced view of immuno-oncology biology.
The PanCancer IO 360 Gene Expression Panel is a unique 770 gene expression panel for research use only (RUO) that combines vital components involved in the complex interplay between the tumor, microenvironment and immune response in cancer allowing for a multifaceted characterization of disease biology and interrogation of mechanisms of immune evasion.
Developed specifically for translational research, this powerful new panel incorporates 15+ potentially predictive Research Use Only (RUO) biological signatures including the 18-gene Tumor Inflammation Signature as recently described in JCI.1
- Translational RUO panel for the research of possible predictive signatures for potential immunotherapy companion diagnostics
- Allows for possible identification of responder/non-responder populations for immunotherapy research
- Characterize disease biology
- Interrogate mechanisms of immune evasion
Tumor-Microenvironment-Immune Response
Tumor Foreignness | Tumor Fitness | Tumor Immune Evasion | Immune Access to Tumor | Inhibitory Metabolism | Cytolytic Immune Activity | Suppressive Immunity | Immune Cell Population Abundance | |
---|---|---|---|---|---|---|---|---|
Antigen processing machinery | Apoptosis | PDL1 gene expression | Stroma abundance | Glycolytic activity | Tumor Inflammation Signature | Myeloid-derived Inflammatory signaling | B-cells | Mast Cells |
Proteasome | Proliferation - Tumor proliferation | IDO1 gene expression | Endothelial cells | Hypoxia | Cytotoxicity | Inflammatory chemokines | CD45 | Neutrophils |
MAGE family gene expression | Loss of JAK-STAT pathway gene expression | Interferon gamma | ARG1 gene expression | CD8 T cells | NK CD56dim cells | |||
Loss of antigen processing and presentation gene expression | Interferon downstream signaling | NOS2 gene expression | Cytotoxic cells | NK cells | ||||
Loss of mismatch repair gene expression | Lymphoid compartment activity | CTLA4 gene expression | DC | T-cells | ||||
Myeloid compartment activity | IL10 gene expression | Exhausted CD8 | Th1 cells (T-bet expression) | |||||
HLA class 2 antigen presentation | PDL2 gene expression | Macrophages | Treg (FOXP3 expression) |
Download Gene List:
-
The Hallmarks of Cancer are one of the most widely recognized organizing principles for the holistic study of cancer. Its profoundly simple framework was first introduced in 2000 b...
-
nCounter PanCancer Pathways Panel Drawing on 30+ years of cancer research, QPCR, Next Generation Sequencing, Gene Expression, Western blotting the cancer community has accomplished...
-
Perform multiplex gene expression analysis with 770 genes from 24 different immune cell types, common checkpoint inhibitors, CT antigens, and genes covering both the adaptive and i...
-
Perform multiplex gene expression analysis with 770 genes from each step in the cancer progression process including: angiogenesis, extracellular matrix remodeling (ECM), epithelia...
-
A Comprehensive Set of Fusion Genes The nCounter Leukemia Fusion Gene Expression Assay Kit allows researchers to profile a comprehensive set of fusion genes which result from balan...
-
nCounter Vantage™ Gene Fusion Panels Multiplexed Gene Fusion Detection Simplified. Save time and sample material with multiplexed gene fusion detection in a single tube. Detect ra...